Scene And Heard At BIO - From The IN VIVO Blog
This article was originally published in The Pink Sheet Daily
Executive Summary
Take our molecules...please! And "Pim's" cup runneth over, from BIO's annual meeting in Chicago.
You may also be interested in...
Two's a Crowd: Versartis Raises $21 Million Series B, Cleaves Off Diabetes Asset to Form Diartis Pharma
Citing different financial needs, Versartis' backers have created Diartis to take its GLP-1 molecule to proof of concept, while Versartis focuses on human growth hormone.
Two's a Crowd: Versartis Raises $21 Million Series B, Cleaves Off Diabetes Asset to Form Diartis Pharma
Citing different financial needs, Versartis' backers have created Diartis to take its GLP-1 molecule to proof of concept, while Versartis focuses on human growth hormone.
Innate Therapeutics Wins $550K From Fast Forward For Therapy Aimed At Progressive MS
Validation from the venture philanthropy garnered the New Zealand biotech another NZD600,000 from the NZ government.